Undergruppeanalyser viste en forskel i positivt behandlingsudfald, hvor 27% ikkehvide kvinder og 39% hvide kvinder viste en markant eller bedre fremgang.
Subgroup analysis revealed a difference in treatment success where 27% of non-white women and 39% of white women showed a marked or better improvement.